Astec LifeSciences Limited has informed the Exchange about General Updates
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At its 31st Annual General Meeting held on 28th July 2025, shareholders of Astec LifeSciences approved the appointment of M/s. BNP & Associates, Company Secretaries, as the Secretarial Auditors of the company. The appointment is for a fixed term of five years, covering Financial Years 2025-26 through 2029-30. The disclosure was made under Regulation 30 of the SEBI Listing Regulations, signed by Company Secretary Tejashree Pradhan. This is a routine governance and compliance-related appointment, with no changes to the board or senior management mentioned.
This is a routine compliance announcement with no material impact on the stock price or shareholder value. It simply formalises the secretarial audit function for the next five years, which is a standard regulatory requirement for listed companies.